• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Clinical Laserthermia Systems

1.83 SEK+1.89 %7.8. klo 18.25
Less than 1K followers

CLS B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.89 %
-45.82 %
-50.91 %
-75.78 %
-73.07 %
-69.17 %
-92.52 %
-99.07 %
-99.25 %

Clinical Laserthermia Systems operates in the medical technology sector. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as in the treatment of malignant melanoma, as well as cancer of the lungs, liver and pancreas. The company was founded in 2006 and has its headquarters in Lund.

Read more
Market cap
95.27M SEK
Turnover
91.49K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
29.8.
2026

Interim report Q2'26

13.11.
2026

Interim report Q3'26

19.2.
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release06.08.2026 klo 09.30

Majority of CLS Board and Key Executive Management Commit to Invest in the Company's Rights Issue

Clinical Laserthermia Systems
Regulatory press release04.08.2026 klo 09.30

CLS: The Subscription Period in Clinical Laserthermia Systems AB' Rights Issue of Units Begins Today

Clinical Laserthermia Systems
Press release26.07.2026 klo 18.22

Redeye: CLS (Q2 Review): Report in line with expectations, focus shifts to financing solution

Clinical Laserthermia Systems

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release23.07.2026 klo 09.30

CLS: Board of Directors of Clinical Laserthermia Systems AB resolves on a rights issue of units of initially approximately SEK 39.5 million

Clinical Laserthermia Systems
Regulatory press release18.07.2026 klo 00.45

CLS Publishes Half-year Report January - June 2026

Clinical Laserthermia Systems
Regulatory press release29.06.2026 klo 20.20

CLS: Communique from the Annual General Meeting on Monday June 29th in Clinical Laserthermia Systems AB

Clinical Laserthermia Systems
Regulatory press release04.06.2026 klo 09.30

CLS: Clinical Laserthermia Systems publishes annual report for 2025

Clinical Laserthermia Systems
Regulatory press release28.05.2026 klo 16.00

CLS enters research agreement with the U.S. National Cancer Institute

Clinical Laserthermia Systems
Regulatory press release28.05.2026 klo 09.30

CLS: Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 29, 2026

Clinical Laserthermia Systems
Press release13.05.2026 klo 12.57

Redeye: CLS (Q1 Review): Well aligned with our expectations

Clinical Laserthermia Systems
Regulatory press release12.05.2026 klo 09.30

CLS Publishes Interim Report January - March 2026

Clinical Laserthermia Systems
Regulatory press release11.05.2026 klo 09.30

CLS Receives Largest Purchase Order Worth SEK 23 Million for Prism[®] Business

Clinical Laserthermia Systems
Regulatory press release28.04.2026 klo 11.45

CLS Strengthens its Strategic Partnership in Neurosurgery and Aims to Become Market Leader in Neuro LITT

Clinical Laserthermia Systems
Press release23.02.2026 klo 11.14

Redeye: CLS Q4 (Review): Low sales due to alignment discussions with ClearPoint Neuro

Clinical Laserthermia Systems
Regulatory press release20.02.2026 klo 09.45

CLS: Clinical Laserthermia Systems AB publishes Year-end report January - December 2025

Clinical Laserthermia Systems
Regulatory press release08.01.2026 klo 09.30

CLS: TRANBERG[®] Thermal Therapy System installed at Andros Clinics for Launch of Ultrasound-Guided Focal Laser Ablation Program in The Netherlands

Clinical Laserthermia Systems
Regulatory press release12.12.2025 klo 22.00

CLS initiates recruitment process for permanent Chief Financial Officer

Clinical Laserthermia Systems
Regulatory press release03.12.2025 klo 09.30

CLS: Clinical Laserthermia Systems Submits CE-Marking Application for its ClearPoint Prism[®][ ]branded Neuro Laser Therapy System seeking European Regulatory Approval for use in Neurosurgery

Clinical Laserthermia Systems
Press release17.11.2025 klo 10.32

Redeye: CLS Q3 (Review) - Soft sales, but better quarters ahead

Clinical Laserthermia Systems
Regulatory press release14.11.2025 klo 09.30

CLS Publishes Interim Report January - September 2025

Clinical Laserthermia Systems